Gastrointestinal stromal tumour, primary site (Q38808): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||
| Property / Linked ICD 10 | |||
| Property / Linked ICD 10: C41.9 / rank | |||
Normal rank | |||
Latest revision as of 04:02, 13 August 2026
This is the most common mesenchymal tumour that arises in the gastrointestinal tract. It is generally immunohistochemically positive for CD117 (KIT), phenotypically paralleling Cajal-cell differentiation, and most examples contain KIT- or PDGFRA-activating mutations. It is most frequent in the stomach and to a lesser degree in the small intestine. The prognosis depends on the tumour size and the mitotic activity.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 2B5B |
||
| English | Gastrointestinal stromal tumour, primary site |
This is the most common mesenchymal tumour that arises in the gastrointestinal tract. It is generally immunohistochemically positive for CD117 (KIT), phenotypically paralleling Cajal-cell differentiation, and most examples contain KIT- or PDGFRA-activating mutations. It is most frequent in the stomach and to a lesser degree in the small intestine. The prognosis depends on the tumour size and the mitotic activity. |
Statements
CID11:2B5B
0 references
dki-india-2B5B
0 references
Concluído
0 references
13 August 2026
0 references
